INCY

Incyte Corporation ·Nasdaq Global Select·Healthcare
120.75 live · 2026-08-12 15:59
55.1%
Brown Bear Score
85.7%
Business Conviction Score
23.8%
Position Health Score
27.4%
Chase Risk
Daily closes

Daily closes · 1Y (252 sessions) · +48.0% · range 81.61–129.93

The Businesswhat the company reports

Business & cash flow

OCF / assets 20.3%
FCF / revenue 27.5%
Gross margin 55.7%
ROIC 30.6%
Forward P/E 13.6

This company does not report capital expenditure in the standard filing tag, so free cash flow cannot be derived and FCF/assets is not shown — common for asset managers, REITs, insurers and utilities. OCF/assets is shown instead, and it is the other measure Brown Bear's testing found to survive. Assets are from the latest annual filing (FY2025).

Price vs Earnings growth

Price has run ahead of forward EPS growth by 34.6pp

Confidence 95.0/100

Takeaway Price has moved further than forward earnings growth currently justifies — worth weighing against the rest of the entry case.

Reported earnings

Next report 2026-10-26 · consensus EPS -3.41

Q2 23 revenue: 954.61mQ2 23 net income: 203.55mQ2 23 EPS: 0.90Q3 23 revenue: 919.02mQ3 23 net income: 171.27mQ3 23 EPS: 0.76Q3 23Q4 23 revenue: 1.01bnQ4 23 net income: 201.08mQ4 23 EPS: 0.89Q1 24 revenue: 880.89mQ1 24 net income: 169.55mQ1 24 EPS: 0.75Q1 24Q2 24 revenue: 1.04bnQ2 24 net income: -444.60mQ2 24 EPS: -2.04Q3 24 revenue: 1.14bnQ3 24 net income: 106.46mQ3 24 EPS: 0.54Q3 24Q4 24 revenue: 1.18bnQ4 24 net income: 201.21mQ4 24 EPS: 0.96Q1 25 revenue: 1.05bnQ1 25 net income: 158.20mQ1 25 EPS: 0.80Q1 25Q2 25 revenue: 1.22bnQ2 25 net income: 405.00mQ2 25 EPS: 2.04Q3 25 revenue: 1.37bnQ3 25 net income: 424.17mQ3 25 EPS: 2.11Q3 25Q4 25 revenue: 1.51bnQ4 25 net income: 299.28mQ4 25 EPS: 1.49Q1 26 revenue: 1.27bnQ1 26 net income: 303.33mQ1 26 EPS: 1.47Q1 26

Revenue Net incomeEPS (GAAP) (-2.04–2.11, own scale) Derived Q4

12 quarters to Q1 26. Revenue and net income share one scale, so the gap between them is the margin. The baseline is zero — bars below it are losses. The line is GAAP EPS — it spans every quarter shown, where the reported figure only goes back as far as the consensus feed does.

Quarter endingRevenueYoY Net incomeEPS (GAAP) EPS reportedvs consensus Filed
2026-03-31 1.27bn +20.9% 303.33m 1.47 1.81 +29.4% 2026-04-28
2025-12-31 (derived) 1.51bn +27.8% 299.28m 1.49 1.80 -8.5% 2026-02-10
2025-09-30 1.37bn +20.0% 424.17m 2.11 2.26 +33.7% 2025-10-28
2025-06-30 1.22bn +16.5% 405.00m 2.04 2025-07-29

Earnings response

Typical move around a filing ±4.2%
On an ordinary two days ±1.4% — filings move it 3.0× as much
Direction 8 up, 3 down over 11 filings
Revenue change and price reaction, by quarter
Q3 22 revenue +1.3% year on yearQ3 22 filed 2022-11-01: price +3.8%Q1 23 revenue +10.3% year on yearQ1 23 filed 2023-05-02: price -9.7%Q1 23Q2 23 revenue +4.7% year on yearQ2 23 filed 2023-08-01: price +3.1%Q3 23 revenue +11.6% year on yearQ3 23 filed 2023-10-31: price +4.2%Q3 23Q1 24 revenue +8.9% year on yearQ1 24 filed 2024-04-30: price +0.7%Q2 24 revenue +9.3% year on yearQ2 24 filed 2024-07-30: price -5.1%Q2 24Q3 24 revenue +23.8% year on yearQ3 24 filed 2024-10-29: price +12.5%Q1 25 revenue +19.5% year on yearQ1 25 filed 2025-04-29: price +5.3%Q1 25Q2 25 revenue +16.5% year on yearQ2 25 filed 2025-07-29: price +10.5%Q3 25 revenue +20.0% year on yearQ3 25 filed 2025-10-28: price -3.1%Q3 25Q1 26 revenue +20.9% year on yearQ1 26 filed 2026-04-28: price +3.5%

Revenue up year on year Revenue down Price move around the filing separate scales — a crossing means nothing

Quarter endingFiledRevenue YoY Move around filingNext 20 sessions vs SPY
2026-03-31 2026-04-28 +20.9% +3.5% -7.7%
2025-09-30 2025-10-28 +20.0% -3.1% +18.3%
2025-06-30 2025-07-29 +16.5% +10.5% +7.5%
2025-03-31 2025-04-29 +19.5% +5.3% -1.0%

Share count

Diluted shares over time

Diluted shares Return since the previous filing

Direction Growing — shares issued
Diluted shares 206.8M as at 2026-03-31
Change over 1 year +4.4%
Change over 3 years -8.3%
Public float $11.20bn as at 2025-06-30 (10-K)

The Pricewhat the chart is doingTop ↑

Price Levels

StrategyFair Value Anchor
Reference band 107.79 — 121.37
Protective stop 103.76 (Atr, 9.4% risk)
Support 115.14 (2 touches, 4.9% away)
Resistance (— away)

Takeaway The shares are about 4.9% above 115.14, a price buyers have stepped in at before. There is no ceiling to point to, because the stock is trading where it has not traded before and nobody has sold it at these levels. That floor has held 2 times, which is how it was spotted. If someone bought at today's price and sold if it dropped through the level below, they would be about 9.4% out of pocket. That is all this figure means — an illustration of the risk, not a price to sell at.

Levels are computed from price structure. They describe where the engine locates support and extension — they are not targets, and not advice.

Ichimoku Cloud (Adaptive)

Daily cloudPrice INSIDE the cloud | periods 5/16/31 (60% of classic 9/26/52)
LinesTenkan/Kijun BULL | cloud twist BEAR (fresh down, 4d ago)
Cloud thickness61% percentile
Chikou spanAbove price from 26 periods ago
Weekly cloudPrice ABOVE the weekly cloud (context only, not scored)

Takeaway The stock is trading inside its cloud — a shaded band drawn from several of its own moving averages, currently 118.57 to 121.58. Inside the band those averages disagree with each other, so the indicator is not saying much either way. Its shorter-term averages point the other way, so this is a mixed reading rather than a clear one.

Trailing returns

21 days +5.1%
63 days +21.8%
126 days +20.7%
252 days +52.5%
Below 252d high7.0%

Trend context

PositionFar above trend
ExtensionExtremely extended
Trend slopeRising
Direction of travelHolding its deviation

Takeaway Extreme upside extension above Kalman fair trend; entry risk is elevated.

Volatility

State No recent compression
Current band width12.0% of price
Recent tightest12.0% (0 sessions ago, narrower than 42.0% of its history)
Expansion since1.00×
Band 112.61 — 127.05

Takeaway Lately this share price has been swinging around inside a range roughly 12% wide. That is normal for this stock, so there is nothing unusual to read into it either way.

Historical trends

0255075100Share price 115.79–129.932026-07-222026-08-12
Position Health Business Conviction Share price

History begins when the site started recording, not when the company listed, so a short line means a short record and nothing more.

Repair Pathway

  1. Nearest Trigger MACD repair streak continuation 4 improving bars MACD histogram has improved for 4 consecutive sessions · Broadly stable
  2. Trigger 2 Volume confirmation above 1.2x +0.20x volume confirmation would improve confidence in the pathway · Broadly stable
  3. Trigger 3 MACD bullish crossover repair trigger repair engine identifies this as the nearest technical repair catalyst · Broadly stable
  4. Trigger 4 Positive 20-day momentum acceleration secondary repair secondary repair catalyst could add confirmation if the primary trigger develops · Broadly stable
  5. Trigger 5 Relative strength stabilisation state change relative momentum rank supports RS stabilisation · Broadly stable

Who's Tradingthe flow behind the priceTop ↑

Insider activity

ActivityNo filings in the window
Buy filings0
Sell filings0

Open-market Form 4 purchases and sales over the last 75 days, read from SEC EDGAR Form 4. Grants, option exercises, gifts and shares withheld for tax are excluded — they are compensation mechanics, not a decision to buy or sell. Reported Form 4 activity. Brown Bear tested insider cluster-buying as a return signal and rejected it as era-unstable; shown as fact, not signal.

Volume confirmation

Volume-price trend Above its signal line
Confirmation Marginal

No absorption or distribution event in the recent window.

Takeaway Slightly more shares change hands on rising days than on falling ones, but the gap is too small to read anything into.

Options Positioning

no listed options chain

Context & Methodthe record, and how it was builtTop ↑

Relative Rotation

ImprovingLeadingLaggingWeakeningvs sectorvs SPYsector vs SPYRS-Ratio →RS-Momentum →

Stock Rotation Headwind

Rotation health 19.8/100; Severe Rotation Headwind.

Rotation health 19.8
Rotation strength 83.6
LegQuadrantRS-RatioRS-Mom
Stock vs sector Lagging 74.7 92.6
Stock vs SPY Lagging 79.8 95.3
Sector vs SPY Improving 86.4 102.1

Direction of travel: South-West / deteriorating rotation

Position only. Brown Bear's RRG redesign programme is closed — five constructions, none beat an appropriate null — so this section describes where the name sits, and is not a signal.

News Headlines

  1. Loading headlines\u2026

Headlines are supplied by third-party feeds and are not written, ranked or interpreted by Brown Bear. They feed no score on this page.

Detailed Scoring

Positive signals

  • Piotroski F-score 7/9 (+20.0)
  • Altman Z-score 16.45 (+10.0)
  • Insider conviction score (+5.0)
  • Gross margin quality: 55.7% (+13.1)
  • ROIC quality: 30.6% (+22.0)
  • FCF margin quality: 27.5% (+18.3)
  • ROIC improving by 22.2 pts (+10.0)
  • FCF margin improving by 19.6 pts (+5.0)
  • High earnings quality (accrual ratio -0.018) (+2.0)
  • Track 1: bullish DI spread 11.3 (+3.0)
  • Track 1: ADX 20.8 and flat (+3.0)
  • Track 1: relative momentum rank 0.85 (+4.4)
  • Track 1: EMA20 reclaim distance 1.3% (+7.0)
  • Track 1: EMA20 slope improving 0.7% (+1.8)
  • Track 1: RSI recovery 56.2, 5-day change +1.6 (+0.9)
  • Track 1: VPT strength 0.04 (+0.8)
  • Track 1: price above EMA50 by 6.0% (+3.8)
  • Track 1: EMA50 slope improving 2.9% (+3.0)
  • Track 1: Bollinger position 0.56 (+3.5)

Negative signals

  • Track 1: weak MACD histogram (-0.52)
  • Track 1: weak volume confirmation (0.52x average)
  • Relative strength versus sector deteriorating
  • Track 1: negative 20-day momentum acceleration (-0.08)
  • Track 1: weak MACD line/signal structure (-5.0)
  • Track 1: MACD slope deteriorating (-3.0)
  • Gross margin improving by -37.0 pts (+-3.0)

Chase risk is not elevated for this name, so extension penalties are omitted from the negative signals above.